Year |
Citation |
Score |
2020 |
Dumond JB, Bay CP, Nelson JAE, Davalos A, Edmonds A, De Paris K, Sykes C, Anastos K, Sharma R, Kassaye S, Tamraz B, French AL, Gange S, Ofotokun I, Fischl MA, et al. Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine. Antimicrobial Agents and Chemotherapy. PMID 32631821 DOI: 10.1128/Aac.00177-20 |
0.315 |
|
2020 |
Ionova Y, Ashenhurst J, Zhan J, Nhan H, Kosinski C, Tamraz B, Chubb A. CYP2C19 allele frequencies in over 2.2 million direct-to-consumer genetics research participants and the potential implication for prescriptions in a large health system. Clinical and Translational Science. PMID 32506666 DOI: 10.1111/Cts.12830 |
0.389 |
|
2018 |
Tamraz B, Huang Y, French AL, Kassaye S, Anastos K, Nowicki MJ, Gange S, Gustafson DR, Bacchetti P, Greenblatt RM, Hysi PG, Aouizerat BE. A genome-wide association study identifies a candidate gene associated with atazanavir exposure measured in hair. Clinical Pharmacology and Therapeutics. PMID 29315502 DOI: 10.1002/Cpt.1014 |
0.344 |
|
2013 |
Tamraz B, Fukushima H, Wolfe AR, Kaspera R, Totah RA, Floyd JS, Ma B, Chu C, Marciante KD, Heckbert SR, Psaty BM, Kroetz DL, Kwok PY. OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis. Pharmacogenetics and Genomics. 23: 355-64. PMID 23652407 DOI: 10.1097/Fpc.0B013E3283620C3B |
0.526 |
|
2012 |
Floyd JS, Kaspera R, Marciante KD, Weiss NS, Heckbert SR, Lumley T, Wiggins KL, Tamraz B, Kwok PY, Totah RA, Psaty BM. A screening study of drug-drug interactions in cerivastatin users: An adverse effect of clopidogrel Clinical Pharmacology and Therapeutics. 91: 896-904. PMID 22419147 DOI: 10.1038/Clpt.2011.295 |
0.493 |
|
2011 |
Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, Kaspera R, Bis JC, Glazer NL, Li G, Austin TR, et al. Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenetics and Genomics. 21: 280-8. PMID 21386754 DOI: 10.1097/Fpc.0B013E328343Dd7D |
0.473 |
|
2010 |
Kaspera R, Naraharisetti SB, Tamraz B, Sahele T, Cheesman MJ, Kwok PY, Marciante K, Heckbert SR, Psaty BM, Totah RA. Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenetics and Genomics. 20: 619-29. PMID 20739906 DOI: 10.1097/Fpc.0B013E32833Ecace |
0.52 |
|
2009 |
Trivedi NN, Tamraz B, Chu C, Kwok PY, Caughey GH. Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations. The Journal of Allergy and Clinical Immunology. 124: 1099-105.e1-4. PMID 19748655 DOI: 10.1016/J.Jaci.2009.07.026 |
0.499 |
|
2007 |
Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A, Choy E, Hu D, Tamraz B, Pawlikowska L, Wassel-Fyr C, Huntsman S, Waliszewska A, Rossin E, Li R, et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. American Journal of Human Genetics. 80: 716-26. PMID 17357077 DOI: 10.1086/513206 |
0.534 |
|
Show low-probability matches. |